Acorda Therapeutics, Inc. Annual Amortization of Intangible Assets in USD from 2012 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
Acorda Therapeutics, Inc. quarterly/annual Amortization of Intangible Assets history and growth rate from 2012 to 2023.
  • Acorda Therapeutics, Inc. Amortization of Intangible Assets for the quarter ending March 31, 2024 was $644K, a 91.6% decline year-over-year.
  • Acorda Therapeutics, Inc. Amortization of Intangible Assets for the twelve months ending March 31, 2024 was $23.7M, a 22.9% decline year-over-year.
  • Acorda Therapeutics, Inc. annual Amortization of Intangible Assets for 2023 was $30.8M, unchanged from 2022.
  • Acorda Therapeutics, Inc. annual Amortization of Intangible Assets for 2022 was $30.8M, unchanged from 2021.
  • Acorda Therapeutics, Inc. annual Amortization of Intangible Assets for 2021 was $30.8M, a 0% increase from 2020.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Annual (USD)
Amortization of Intangible Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $30.8M $0 0% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-01
2022 $30.8M $0 0% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-01
2021 $30.8M +$1K +0% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-15
2020 $30.8M +$5.13M +20% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-18
2019 $25.6M +$24M +1435% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-16
2018 $1.67M -$22.1M -93% Jan 1, 2018 Dec 31, 2018 10-K 2020-02-28
2017 $23.8M +$14.7M +161% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-28
2016 $9.1M +$6M +194% Jan 1, 2016 Dec 31, 2016 10-K/A 2018-03-09
2015 $3.1M -$200K -6.06% Jan 1, 2015 Dec 31, 2015 10-K 2017-02-27
2014 $3.3M +$900K +37.5% Jan 1, 2014 Dec 31, 2014 10-K 2016-02-29
2013 $2.4M -$200K -7.69% Jan 1, 2013 Dec 31, 2013 10-K 2015-02-27
2012 $2.6M Jan 1, 2012 Dec 31, 2012 10-K 2014-03-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.